WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Merck Group

MerckMerck is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses - Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials - and generated sales of € 11.3 billion in 2014. Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials.

www.merckgroup.com

Merck KGaA RSS Channel

Filters
List of articles in category Merck Group
Title Published Date
Merck partners with American Cancer Society to address cancer in women 01 November 2016
Get your startup to the next level 24 October 2016
Merck announces recipients of third annual €1 million 'Grant for Oncology Innovation' award 10 October 2016
Merck commits €1.5 million to the Grant for Fertility Innovation (GFI) for 2016/17 06 July 2016
Merck Family Foundation established 20 June 2016
Merck in agreement with HAPPYneuron to offer first-of-its kind e-Health solution for people living with multiple sclerosis 13 June 2016
Merck Accelerator expands its reach to Silicon Valley 09 June 2016
Merck announces survey results exploring biopharma industry's evolving risk model 07 June 2016
Merck brings international start-up-companies to Darmstadt and Nairobi 26 April 2016
Merck and the European Molecular Biology Laboratory announce drug discovery collaboration 03 March 2016
Merck announces new biopharma heads for North America and China 27 January 2016
Merck and Pfizer receive FDA Breakthrough Therapy designation for avelumab in metastatic Merkel cell carcinoma 18 November 2015
Merck recognized for digital workplace platform 09 November 2015
Merck brand relaunched 14 October 2015
Merck's Consumer Health business counts on Latin America for growth 30 September 2015
Merck announces application period for start-ups 30 July 2015
Merck to acquire Sigma-Aldrich to enhance position in attractive life science industry 22 September 2014
Merck strengthens commitment to Chinese growth market 23 July 2014
Merck Serono announces Global Grants Program to fund scientific innovation 09 July 2014
Merck Serono enters into research agreement with Pfizer and Broad Institute 02 April 2014
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • End
Tahmeena

Business & Industry

  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
  • Acquisition of Neogene Therapeutics completed

Research & Development

  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway
  • A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
  • 500,000 missed out on blood pressure lowering drugs during pandemic

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Merck Group
  4. Merck is celebrating its anniversary by conducting 350 charitable activities in around 60 countries

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.